Advisory Committee on the Medical Uses of Isotopes: Meeting Notice
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on August 29, 2024, to discuss the ACMUI's draft subcommittee report on its review and recommendations on staff's regulatory basis for the rulemaking to amend financial assurance requirements for disposition of category 1-3 byproduct material radioactive sealed sources. Meeting information, including a copy of the agenda and handouts, will be available on the ACMUI's Meetings and Related Documents web page at https://www.nrc.gov/reading-rm/doc-collections/ acmui/meetings/2024.html or by emailing Ms. L. Armstead at the contact information below. Date: August 29, 2024, from 2:00 p.m. to 4:00 p.m. Eastern Time.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 134 (Friday, July 12, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 134 (Friday, July 12, 2024)]
[Notices]
[Pages 57173-57174]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-15325]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a
meeting of the Advisory Committee on the Medical Uses of Isotopes
(ACMUI) on August 29, 2024, to discuss the ACMUI's draft subcommittee
report on its review and recommendations on staff's regulatory basis
for the rulemaking to amend financial assurance requirements for
disposition of category 1-3 byproduct material radioactive sealed
sources. Meeting information, including a copy of the agenda and
handouts, will be available on the ACMUI's Meetings and Related
Documents web page at <a href="https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html">https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html</a> or by emailing Ms. L. Armstead at the contact
information below.
Date: August 29, 2024, from 2:00 p.m. to 4:00 p.m. Eastern Time.
Address for Public Meeting: This is a virtual meeting.
------------------------------------------------------------------------
Date Webinar information (Microsoft Teams)
------------------------------------------------------------------------
August 29, 2024.............. Link: <a href="https://teams.microsoft.com/l/meetup-join/19%3ameeting_NmZmMDUwYzgtNTZlYS00YmI1LWI4OGItMjJjMDYyZGRkNTk2%40thread.v2/0?context=%7b%22Tid%22%3a%22e8d01475-c3b5-436a-a065-5def4c64f52e%22%2c%22Oid%22%3a%22304f46bf-32c2-4e0f-912c-878db895e74a%22%7d">https://teams.microsoft.com/l/meetup-join/19%3ameeting_NmZmMDUwYzgtNTZlYS00YmI1LWI4OGItMjJjMDYyZGRkNTk2%40thread.v2/0?context=%7b%22Tid%22%3a%22e8d01475-c3b5-436a-a065-5def4c64f52e%22%2c%22Oid%22%3a%22304f46bf-32c2-4e0f-912c-878db895e74a%22%7d</a>.
Meeting ID: 254 136 027 833.
Passcode: nxAuiE.
Call in number (audio only): +301-576-
2978, United States, Silver Spring.
Phone Conference ID: 901 692 104#.
------------------------------------------------------------------------
Public Participation: The meeting will be held using Microsoft
Teams. Any member of the public who wishes to participate in the
meeting via Microsoft Teams or via phone can use the information
provided above or should contact Ms. L. Armstead. Members of the public
should also monitor the NRC's Public Meeting Schedule at <a href="https://www.nrc.gov/pmns/mtg">https://www.nrc.gov/pmns/mtg</a> for any meeting updates.
Contact Information: Ms. L. Armstead, email: <a href="/cdn-cgi/l/email-protection#c5a9bda4f085abb7a6eba2aab3"><span class="__cf_email__" data-cfemail="204c584115604e52430e474f56">[email protected]</span></a>,
telephone: 301-415-1650.
[[Page 57174]]
Conduct of the Meeting
The ACMUI Chair, Dr. Hossein Jadvar will preside over the meeting.
Dr. Jadvar will conduct the meeting in a manner that will facilitate
the orderly conduct of business. The following procedures apply to
public participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. L. Armstead using the contact information listed
above. All submittals must be received by the close of business on
August 23, 2024, and must only pertain to the topics on the agenda.
2. Questions and comments from members of the public will be
permitted during the meeting, at the discretion of the ACMUI Chair.
3. The draft transcript and meeting summary will be available on
ACMUI's website <a href="https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html">https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html</a> on or about September 23, 2024.
4. Persons who require special services, such as those for the
hearing impaired, should notify Ms. L. Armstead of their planned
participation.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily section 161a); the Federal Advisory
Committee Act (5 U.S.C. app); and the Commission's regulations in title
10 of the Code of Federal Regulations, part 7.
Dated at Rockville, Maryland this 9th day of July, 2024.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2024-15325 Filed 7-11-24; 8:45 am]
BILLING CODE 7590-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.